Large intestinal endocrine cells in non-obese diabetic mice

Journal of Diabetes and its Complications

Volumn 12, Issue 6, 1998, Pages 321-327

  Spångéus, Anna ^a   El Salhy, Magdy ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL MODEL; ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; ENDOCRINE CELL; FEMALE; IMAGE ANALYSIS; IMMUNOCYTOCHEMISTRY; INTESTINE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BIOLOGICAL MARKERS; COLON; DIABETES MELLITUS, TYPE 1; ENTEROENDOCRINE CELLS; FEMALE; GLUCAGON-LIKE PEPTIDES; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; PEPTIDE YY; PREDIABETIC STATE; REFERENCE VALUES; SEROTONIN;

EID: 0032214533     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(98)00007-5     Document Type: Article

References (39)

1. Locke G.R. III Epidemiology of gastrointestinal complications of diabetes mellitus. Eur J Gastroenterol Hepatol. 7:1995;711-716.
2. Feldman M., Schiller L.R. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med. 98:1983;378-384.
3. Bargen J.A., Bollman J.L., Kepler E.J. The "diarrhea of diabetes" and steatrrhoea of pancreatic insufficiency. Mayo Clin Proc. 11:1936;737-742.
4. Kassander P. Asymptomatic gastric retention in diabetics (gastroparesis diabeticorum). Ann Intern Med. 48:1958;797-812.
5. Spengler U., Stellard F., Ruckdeschel G., Scheurlen C., Kruis W. Small intestinal transit, bacterial growth, and bowel habits in diabetes mellitus. Pancreas. 4:1989;65-70.
6. Wegener M., Börsch G., Schaffstein J., Luerweg C., Leverkus F. Gastrointestinal transit disorders in patients with insulin-treated diabetes mellitus. Dig Dis Sci. 8:1990;23-36.
7. Clark D.W., Nowak T.V. Diabetic gastroparesis - What to do when gastric emptying is delayed. Postgrad Med. 95:1994;195-204.
8. Change E.B., Fedorak R.N., Field M. Experimental diabetic diarrhea in rats-intestinal mucosal denervation hypersensitivity and treatment with clonidine. Gastroenterology. 91:1986;564-569.
9. Clouse R.E., Lustman P.J. Gastrointestinal symptoms in diabetic patients. Lack of association with neuropathy Am J Gastroenterol. 84:1989;868-872.
10. Maxton D.G., Whorwell P.J. Functional bowel symptoms in diabetes - the role of autonomic neuropathy. Postgrad Med J. 67:1991;991-993.
11. Shanahan F., Anton P.A. Role of peptides in the regulation of the mucosal immune and inflammatory response. Walsh J.H., Dockary G.J. Gut Peptides. Biochemistry and Physiology:1994;851-867 Raven, New York.
12. Mayer E.A., Raybould H., Koelbel C. Neuropeptides, inflammation, and motility. Dig Dis Sci. 33:1988;71-77.
13. Allescher H.D. Postulated physiological and pathophysiological roles on motility. Daniel E.E. Neuropeptides Function in Gastrointestinal Tract. 1991;309-400 CRC Press, Boca Raton.
14. Ekblad E., Håkanson R., Sundler F. Microanatomy and chemical coding of peptide-containing neurones in the digestive tract. Daniel E.E. Neuropeptides Function in Gastrointestinal Tract. 1991;131-180 CRC Press, Boca Raton.
15. Rangachari P.K. Effects of neuropeptides on intestinal ion transport. Daniel E.E. Neuropeptides Function in Gastrointestinal Tract. 1991;429-446 CRC Press, Boca Raton.
16. Lysy J., Karmeli F., Goldin F. Substance P levels in rectal mucosa of diabetic patients with normal bowel function and constipation. Scand J Gastroenterol. 28:1993;49-52.
17. Portela-Gomes G.M., Wilander E., Grimelius L., Bergström R., Ruhn G. The enterochromaffin cells in the mouse gastrointestinal tract after streptozotocin treatment. Pathol Res Pract. 186:1990;260-264.
18. Pinto H.C., Portela-Gomes G.M., Grimeslius L., Kohnert K.-D., De Sousa J.C., Pinto Albuquerque M.A. The distribution of endocrine cell types of the gastrointestinal mucosa in genetically diabetic (db/db) mice. Gastroenterology. 108:1995;967-974.
19. Lincoln J., Bokor J.T., Crowe R., Griffith S.G., Haven A.J., Burnstock G. Myenteric plexus in streptozotocin treated rats. Gastroenterology. 86:1984;654-661.
20. Di Giulio A.M., Tenconi B., La Croix R., Mantegazza P., Cattabeni F., Gorio A. Denervation and hyperinnervation in the nervous system of diabetic animals. I. The autonomic neuronal dystrophy of the gut. J Neurosci Res. 24:1989;355-361.
21. Nwokolo C.U., Debnam E.S., Booth J.D., Sim R., Sankey E.A., Dhillon A.P., Pounder R.E. Neuroendocrine changes in rat stomach during experimental diabetes mellitus. Dig Dis Sci. 37:1992;751-756.
22. El-Salhy M, Zachrisson S, Spångéus A: Abnormalities of small intestinal endocrine cells in non-obese diabetic (NOD) mice. Diabet Complications 1998 (in press).
23. El-Salhy M., Spångéus A. Substance P in gastrointestinal tract of non-obese diabetic (NOD) mice. Scand J Gastroenterol. 33:1998;394-400.
24. Makino S., Kunimoto K., Muraoka Y., Mitzushima Y., Katagiri K., Tochino Y. Breeding of non-obese diabetic (NOD) strain of mice. Exp Anim. 29:1980;1-13.
25. Tochino Y: The NOD mouse as a model of type I diabetes. CRC Crit Rev Immunol 8:49-81, 1987.
26. Kolb H. Mouse models of insulin-dependent diabetes. Low dose streptozotocin-induced diabetes and non-obese diabetic (NOD) mice Diabetes Metab Rev. 3:1987;751-778.
27. Fujishima Y., Koike Y., Kaidoh T., Nishimura M., Yoshida T.O. Restriction fragment length polymorphism analysis of major histocompatibility complex genes in non-obese diabetic mouse strain and its sister strains. Diabetologia. 32:1989;118-125.
28. El-Salhy M., Stenling R., Grimelius L. Peptidergic innervation and endocrine cells in the human liver. Scand J Gastroenterol. 28:1993;809-815.
29. El-Salhy M., Sandström O., Näsström E., Mustajbasic M., Zachrisson S. Application of computer image analysis in endocrine cell quantification. Histochem J. 29:1997;249-256.
30. El-Salhy M., Lundqvist M. Immunocytochemical investigation of polypeptide YY (PYY) and pancreatic polypeptide (PP) in the gastrointestinal tract of three rodents. Biochem Res. 5:1984;401-404.
31. Walsh JH: Gastrointestinal hormones; enteroglucagons in Johnson LR, Alpers DH, Christensen J, Jacobson ED, Walsh JH (eds), Physiology of the Gastrointestinal Tract, 3rd edition. New York, Raven, 1994, pp. 95-106.
32. Lidberg P. On the role of substance P and serotonin in the pyloric motor control. An experimental study in cat and rat. Acta Physiol Scand. 538(suppl):1985;1-69.
33. Goarard D.A., Libby G.W., Farthing M.J. 5-Hydroxytryptamine and human intestinal motility. Effect of inhibiting 5-hydroxytryptamine uptake Gut. 35:1994;496-500.
34. Tally N.J. Review article. 5-Hydroxytryptamine agonists and antagonists in modulation of gastrointestinal motility and sensation: Clinical implications Aliment Pharmacol Ther. 6:1992;273-289.
35. von der Ohe M.R., Hanson R.B., Camilleri M. Serotogenic mediation of postprandial colonic tonic and phasic response in humans. Gut. 35:1994;536-541.
36. Oosterbosch L., von der Ohe M.R., Valdovinos M.A., Kost L.J., Phillips S.F., Camilleri M. Effects of serotonin on rat ileocolonic transit and fluid transfer in vivo. Possible mechanisms of action Gut. 34:1993;794-798.
37. Mannon P., Taylor I.L. The pancreatic polypeptide family. Johnson L.R., Alpers D.H., Christensen J., Jacobson E.D., Walsh J.H. Physiology of the Gastrointestinal Tract. 1994;341-370 Raven, New York. 3rd edition.
38. El-Salhy M., Grimelius L., Wilander E., Ryberg B., Terenius L., Lundberg J.M., Tatemoto K. Immunocytochemical identification of Polypeptide YY (PYY) cells in human gastrointestinal tract. Histochemistry. 77:1983;15-23.
39. Nakayama H., Tju M., Nakagawa S. Influence of diet on intestinal cell DNA synthesis in the diabetic rat. Diabetes. 23:1974;793-795.